Refractory Anaplastic Large Cell Lymphoma

specific

An anaplastic large cell lymphoma that is resistant to treatment.

29

Centers

23

Active Trials

Cancer Funding

Top Centers for Refractory Anaplastic Large Cell Lymphoma(29)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.7
2
NCI Clinical
High-Volume Research Center
72.7
3
NCI Comprehensive
Active Research Program
56.4
4
NCI Comprehensive
Active Research Program
56.4
5
NCI Comprehensive
Active Research Program
56.4
6
NCI Comprehensive
Active Research Program
56.4
7
NCI Comprehensive
Active Research Program
56.4
8
NCI Comprehensive
Active Research Program
56.4
9
NCI Comprehensive
Active Research Program
56.4
10
NCI Comprehensive
Active Research Program
56.4
11
NCI Comprehensive
Active Research Program
56.4
12
NCI Comprehensive
Active Research Program
56.4
13
NCI Comprehensive
Active Research Program
56.4
14
NCI Clinical
Active Research Program
56.4
15
NCI Comprehensive
Active Research Program
56.4
16
NCI Comprehensive
Active Research Program
56.4
17
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
56.4
18
Active Research Program
56.4
19
Active Research Program
56.4
20
Active Research Program
56.4
21
Active Research Program
56.4
22
NCI Comprehensive
35.4
23
NCI Comprehensive
35.4
2435.4
2535.4
26
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
35.4
2735.4
2835.4
2935.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →